Information:
Error:
ID
13486
Description
Randomized study with a run-in dose-selection phase to assess the added value of Lenalidomide in combination with standard remission-induction chemotherapy and post-remission treatment in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or high risk myelodysplasia (MDS) (IPSS-R risk score> 4.5) Description of Form: Lenalidomide Maintenance Treatment Form
Keywords
Versions (3)
- 11/9/15 11/9/15 -
- 12/28/15 12/28/15 -
- 2/11/16 2/11/16 -
Uploaded on
February 11, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Lenalidomide Maintenance Treatment Form HOVON 132 AML/SAKK 30/13 EudraCT 2013-002843-26
Lenalidomide Maintenance Treatment Form
- StudyEvent: ODM
Similar models
Lenalidomide Maintenance Treatment Form
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item
Form related to administration
integer
C1276413 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
C2348792 (UMLS CUI [1,2])
CL Item
maintenance 1 (11)
C0481504 (UMLS CUI-1)
CL Item
maintenance 4 (14)
C0481504 (UMLS CUI-1)
CL Item
maintenance 2 (12)
C0481504 (UMLS CUI-1)
CL Item
maintenance 5 (15)
C0481504 (UMLS CUI-1)
CL Item
maintenance 6 (16)
C0481504 (UMLS CUI-1)
CL Item
maintenance 3 (13)
C0481504 (UMLS CUI-1)
Date start Lenalidomide
Item
Date start Lenalidomide
date
C0808070 (UMLS CUI [1,1])
C1144149 (UMLS CUI [1,2])
C1144149 (UMLS CUI [1,2])
Lenalidomide Total dose actually given
Item
Lenalidomide Total dose actually given
float
C2986497 (UMLS CUI [1,1])
C1144149 (UMLS CUI [1,2])
C1144149 (UMLS CUI [1,2])
Item
Lenalidomide Dosage
integer
C0178602 (UMLS CUI [1,1])
C1144149 (UMLS CUI [1,2])
C1144149 (UMLS CUI [1,2])
CL Item
full dose according to schedule (1)
CL Item
full dose given but start of treatment delayed (2)
CL Item
daily dose reduced >10% (3)
CL Item
daily dose reduced and start delayed (4)
CL Item
not given (5)
CL Item
interrupted during the cycle and resumed (6)
CL Item
stopped early (7)
CL Item
other (specify) (8)
CL Item
hematological toxicity (1)
C0279810 (UMLS CUI-1)
C0013221 (UMLS CUI-2)
C0013221 (UMLS CUI-2)
CL Item
non-hematological toxicity (specify) (2)
C0013221 (UMLS CUI-1)
CL Item
other (specify) (8)
C0205394 (UMLS CUI-1)
Comments
Item
Comments
text
C0947611 (UMLS CUI [1])